{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-164461","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.120224+00:00","generated_at":"2026-06-01T03:23:18.949843+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Viridian shareholders approve 2M share increase for equity plan; directors elected","bullets":["Amendment to 2016 equity plan approved (32.2M for, 24.3M against), adding 2M shares to reserve.","Class III directors Stephen Mahoney and Arlene M. Morris elected; Morris received 24.9M withheld votes.","Advisory vote on exec compensation passed: 32.8M for, 23.7M against.","Ratification of KPMG as independent auditor passed: 58.4M for, 31.7K against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-164461","json":"https://secwatch.observer/filing/0001193125-24-164461.json","markdown":"https://secwatch.observer/filing/0001193125-24-164461.md","text":"https://secwatch.observer/filing/0001193125-24-164461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312524164461/0001193125-24-164461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312524164461/d857947d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:23:18.949843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}